Visalytics
Visalytics
approved EB-2 (NIW)

ORISE Fellow

Pharmaceutical Sciences · China · 2025-08-08

Processing Time
145 days
Decision Date
2025-08-08
Location
Arkansas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance research on drug-induced liver injury (DILI) by developing a comprehensive database integrating animal and in vitro study findings. The work focuses on investigating the efficacy of replacing animal testing with in vitro models to predict DILI risks, aiming to accelerate safer and more cost-effective drug development processes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses drug-induced liver injury, which impacts tens of thousands of U.S. citizens and carries significant public health and economic implications.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of six publications in high-impact journals and 148 citations demonstrates their influence and capability in the field.

3 Balance of Interests Met

The work promotes animal welfare and reduces healthcare costs, making it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of six peer-reviewed journal articles with 148 citations, including papers ranked in the top 1% and 10% of their field. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of addressing DILI and the petitioner's established expertise through peer review service for respected journals.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Doctor

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
49 days 2024-06-05
The petitioner proposes to continue his research in hepatology, specifically focusing on improving treatment strategies for acute and chronic liver failure through mRNA nanoparticles for targeted drug delivery and macrophage-targeted therapies.
View Case

Postdoctoral Researcher

Biotechnology · Nigeria

WeGreened EB-2 (NIW) approved
7 days 2024-03-21
The petitioner proposes to conduct translational research focused on identifying molecular targets with therapeutic potential to develop effective treatments for liver cancer and other cancer types characterized by dysregulation. Her work utilizes in silico modeling and direct pharmacological tests of candidate compounds to address the global burden of liver cancer.
View Case

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Iowa 320 days 2025-03-26
The petitioner proposes to continue research into gastrointestinal and liver diseases, focusing on improving diagnosis, management, and treatment. His work utilizes behavioral and therapeutic strategies to address both the primary diseases and the chronic pain associated with long-term hepatic conditions.
View Case

Research Assistant

Engineering · Turkey

WeGreened EB-2 (NIW) approved
New Jersey 213 days 2022-09-30
The petitioner intends to develop noninvasive medical diagnostic methods for identifying the mechanical properties of the human liver to be used as biomarkers in the diagnosis of liver fibrosis. This work utilizes advanced MRI techniques to acquire mechanical properties of soft tissues in vivo to gain insight into liver disorders.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 145 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist